At a glance
- Originator Merck & Co
- Class Antiretrovirals; Naphthyridines; Small molecules
- Mechanism of Action HIV integrase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 08 Sep 2004 Phase-I clinical trials in HIV infections treatment in USA (unspecified route)